Skip to content

A New Portable Device for Non-invasive Ventilatory Support

A New Portable Device for PRE-hospital Non-invasive VENTilatory Support in Acute Respiratory Failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06716502
Acronym
PREVENT
Enrollment
50
Registered
2024-12-04
Start date
2025-09-17
Completion date
2026-06-19
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Respiratory Disease

Keywords

CPAP, NIV, Respiratory failure

Brief summary

Acute respiratory failure is a medical emergency rapidly leading to death, if not timely treated. Prompt Continuous Positive Airway Pressure (CPAP) improves patient outcomes. However, pre-hospital CPAP is currently limited to healthcare providers due to the absence of easy-to-use and immediate devices specifically designed for the non-medical population. The efficacy and usability of a new portable CPAP device will be assessed. This device is specifically designed for potential use in out-of-hospital scenarios involving acute respiratory failure. The evaluation will focus not only on the performance of the device but also on its easiness of use.

Detailed description

The efficacy and usability of a new portable CPAP device will be assessed in different clinical settings. The study will take place in three hospitals in Italy, with the objective of collecting data to support the future implementation of the device as a first-aid support tool for patients with respiratory failure in real-world scenarios.

Interventions

DEVICEPortable CPAP efficacy

The device will be tested in providing a PEEP comprised between 4-7,5 cmH2O

DEVICEPortable CPAP usability assessment

The device usability will be evaluated in individual's self-experience tests, i.e., in conditions where the volunteer will self-apply the device.

Sponsors

Università Vita-Salute San Raffaele
Lead SponsorOTHER
Azienda Ospedaliera Universitaria Integrata Verona
CollaboratorOTHER
Città di Lecce Hospital
CollaboratorUNKNOWN

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Arm 1 Inclusion Criteria: 1. Age ≥65 years 2. Clinically stable: non-hospitalized and not in acute illness 3. no professional medical knowledge: no experience as a health care provider 4. Ability to express informed consent as requested by the ethical committee Arm 1

Exclusion criteria

none Arm 2 Inclusion Criteria: 1. Hospitalized adult patient 2. SpO2 of 90-93% in room air Arm 2

Design outcomes

Primary

MeasureTime frameDescription
Device easiness-to-useUp to 2 hoursVolunteers in self-experience tests will be asked to assign a score depending on the easiness-to-use of the device and comfort during the device operation. A semantic differential scale will be used between "hard to use" (corresponding to the score 1) and "easy to use" (corresponding to the score 5). The best result is represented by a higher score, with 5 being the highest and 1 the lowest.
Duration of proper pressure deliveryUp to 2 hoursTotal time of target pressure (4 - 15 cmH2O) during 15-min test
Battery power consumption and durationUp to 2 hoursWe will set 15 minutes of continuous device operation as an efficacy threshold and will assess the battery status at the end of each experiment.
Change in SpO2 levelUp to 2 hoursChange in SpO2 before and during the device application

Countries

Italy

Contacts

CONTACTGiovanni Landoni, MD
landoni.giovanni@hsr.it+39 022643
CONTACTRosalba Lembo
lembo.rosalba@hsr.it+39 022643
STUDY_CHAIRGiovanni Landoni, MD

IRCCS San Raffaele

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026